Lombard C, Deeks AA, Teede H. A Systematic Review of Interventions aimed at the Prevention of Weight Gain in Adults. Public Health Nutrition 2009; 12(11):2236-46
Deeks A, Lombard C, Michelmore J, Teede H. The effects of gender and age on health related behaviors. BMC Public Health 2009; 9:213
Lombard CB, Deeks AA, Ball K, Jolley D, Teede HJ. Weight, physical activity and dietary behaviour change in a population of young mothers: short term results of the HeLP-her cluster randomized controlled trial. Nutrition Journal 2009; 8:17
Van Die MD, Bone KM, Burger HG, Teede HJ. Are we drawing the right conclusions from randomised placebo-controlled trials? BMC Medical Research Methodology 2009; 9(1):41
Moran LJ, Teede HJ. Metabolic features of the reproductive phenotypes of Polycystic Ovary Syndrome. Human Reproduction Update 2009; 15: 477-488
Van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus in the Treatment of Menopause-related Complaints. Journal of Alternative and Complementary Medicine 2009; 15(8) 853-862
Van Die MD, Bone KM, Burger HB, Reece JE, Teede HJ. Effects of a combination of Hypericum Perforatum and Vitex agnus-castus on PMS like symptoms in Late-Perimenopausal Women: Preliminary Findings from a Subpopulation Analysis. Journal of Alternative and Complementary Medicine 2009; 15(5):1-4
Moran LJ, Hutchison SK, Meyer C, Zoungas S, Teede HJ. A comprehensive assessment of endothelial function in overweight women with and without Polycystic Ovary Syndrome. Clinical Science 2009 May; 116(10):761-70
Lombard C, Deeks A, Jolley D, Teede HJ. Preventing weight gain: the baseline weight related behaviors and delivery of a randomized controlled intervention in community based women. BMC Public Health 2009 Jan 3; 9:2
Van Die MD, Burger HG, Bone KM, Cohen MM, Teede HJ. Hypericum perforatum with Vitex agnus-castus in Menopausal Symptoms. Menopause 2009; 16(1):156-163
Van Die D, Teede HJ. Predictors of the Placebo Response in a Randomised Controlled Trial of Phytotherapy in Menopause. Menopause 2009; 16(4):792-6
Moran LJ, Pasquali R, Teede HJ, Hoeger K, Norman R. Androgen Excess and Polycystic Ovary Syndrome International Position Statement: Treatment of obesity in Polycystic Ovary Syndrome. Fertility and Sterility 2009; 92 (6): 1966-82
Teede HJ, Lombard C, and Deeks A. Obesity, metabolic complications and the menopause: an opportunity for prevention. Climacteric. 2010 Jun;13(3):203-9
Lombard C and Teede HJ. Preventing obesity in women of all ages -a public health priority. Diabetes Voice, May 2009; vol 54, special edition
Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. The effect of weight loss on anti-müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment. Human Reproduction 2009; 24 (8): 1976-81.
Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. British Journal of Obstetrics and Gynaecology 2009; 116 (9): 1242-50.
Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes for overweight women with Polycystic Ovary Syndrome. Cochrane Database of Systematic Review 2008; 4:1-10
Zoungas S, Kerr PG, Lui M, Teede HJ. The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes. Nephrology 2008 Apr; 13(2):124-7
Rachon D, Teede H. Postmenopausal hormone therapy and the risk of venous thromboembolism. Climacteric 2008; 11(4):273-279
Hutchison S, Harrison C, Stepto N, Teede H, Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome. Diabetes Care 2008; 31 1427-1432
Deeks A, Zoungas, S, Teede H. Risk Perception in Women: a focus on Menopause. Menopause 2008; 15(2): 304-309
Wong JLA, Lu Z, Doery J, Fuller P. Lessons from a Review of Thyroglobulin Assays in the Management of Thyroid Cancer. IMJ 2008; 38:6;441-444
Moran LJ, Hutchison SK, Meyer C, Zoungas S, Teede HJ. A comprehensive assessment of endothelial function in overweight women with and without Polycystic Ovary Syndrome. Clinical Science 2008; 116 (10): 761-70.
Teede HJ, Jayasuriya IA, Gilfillan CP. Fracture prevention strategies in patients presenting to Australian Hospitals with minimal-trauma fractures: a major treatment gap. Internal Medicine Journal 2007; 37 (10): 674-679
Peverill RE, Teede HJ, Malan E, Kotsopoulos D, Smolich JS, McGrath BP. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. Clinical Science(London) 2007; 113 (9): 383-391
Teede, H, Stuckey B. PCOS and abnormal glucose tolerance. Med J Australia 2007; 187 (6): 324-325
Teede HJ, Zoungas S, Hutchison S. The Management of Insulin Resistance in PCOS. Trends in Endocrinology and Metabolism 2007; 18 (7): 273-279
Meyer C, McGrath BP, Teede HJ. The effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007; 30(3); 471-478.
Teede, HJ. Sex Hormones and the Cardiovascular System: Effects on Arterial Function in Women. Clin Exp Physiol, Pharmacol 2007; 34: 672-676
Hutchison S, Zoungas S, Teede HJ. Insulin levels, insulin resistance and the use of metformin in polycystic ovary syndrome. Med J Australia 2007; 186(5):268-9
Grossmann M, Fuller P, Hunter A, Teede H. Isolated ACTH deficiency presenting as severe hypercalcaemia. Clinical Endocrinology 2007; 66 (4), 603-604.
Moran LJ, Noakes M, Clifton P, Norman RJ, Fenech M. Genome instability is increased in lymphocytes of women with Polycystic Ovary Syndrome and is correlated with insulin resistance. Mutation Research 2007; 639(1-2):55-63.
Moran LJ, Noakes M, Clifton P, Norman RJ. The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism 2007; 92(10):3796-802.
Moran LJ, Noakes M, Clifton P, Wittert GA, Le Roux C, Ghatei M, Bloom S, Norman RJ. Post-prandial ghrelin, cholecystokinin, PYY, appetite and food consumption before and after weight loss in overweight women with and without Polycystic Ovary Syndrome. The American Journal of Clinical Nutrition 2007; 86(6):1603-10.
Galletly C, Moran L, Noakes M, Clifton P, Tomlinson L, Norman R. Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome-A pilot study. Appetite 2007; 49(3): 590-3.
Moran LJ, Noakes M, Clifton P, Wittert GA, Belobrajdic D, Norman RJ. C-reactive protein before and after weight loss in overweight women with and without Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism 2007; 92(8): 2944-51.
Teede HJ, Giannopoulos D, Dalais FS, Hodgson J, McGrath BP. Randomised, Controlled, Cross-Over Trial of Soy Protein with Isoflavones on Blood Pressure and Arterial Function in Hypertensive Subjects. J Am Coll J Clin Nutrition, December 2006, 25(6):533-40.
Teede HJ. Polycystic ovarian syndrome- Update. Diabetes Management Journal 2006, 16: 54-63.
Teede HJ, Norman R. Polycystic ovarian syndrome: insights into the enigma that is PCOS today. Endocrine 2006; 30(1):1-2
Teede HJ, Zoungas S, Hutchison S, Meyer C. Insulin resistance, Metabolic syndrome, diabetes and Cardiovascular disease in Polycystic Ovarian Syndrome. Endocrine 2006; 30(1):45-53
Booth AO, Nowson CA, Huang N, Lombard C, Singleton KL. Evaluation of a brief pilot nutrition and exercise intervention for the prevention of weight gain in general practice patients. Public Health Nutrition 2006 Dec; 9(8):1055-61
Teede, HJ, Meyer C, Norman R. Insulin Sensitisers in the treatment of PCOS. Expert Opinion in Pharmacotherapy 2005; 6(14): 2005 : 2419-2427.
Meyer C, McGrath BP, HJ. Teede. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. Journal of Clinical Endocrinology & Metabolism 2005; 90(10):5711-6
Teede HJ, FS Dalais, D Kotsopoulos, BP McGrath, E Malan, TE Gan, RE Peverill. Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women. Journal of Clinical Endocrinology & Metabolism 2005; 90(4):1936-41
Meyer C, Talbot M, Teede HJ. Effect of Implanon on insulin resistance in women with Polycystic Ovary Syndrome. Australian & New Zealand Journal of Obstetrics & Gynaecology 2005; 45(2):155-8
Meyer C, McGrath B, Cameron J, Teede HJ. Vascular dysfunction and metabolic parameters in polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism 2005; 90(8):4630-5
Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric. 2004 Dec; 7(4):375-89.
Teede HJ. Hormone therapy--weighing up the evidence. Aust Fam Physician. 2004 Nov; 33(11):875-80.
Teede HJ, Reddish S, Deeks AA, Farrell E, Murkies A. Menopause forum--a case discussion on midlife issues. Aust Fam Physician. 2004 Nov; 33(11):903-5.
Reddish S. Menopause--a treatment algorithm. Aust Fam Physician. 2004 Nov; 33(11):900-1.
Reddish S. Assessment of women in midlife. Aust Fam Physician. 2004 Nov; 33(11):883-7.
Deeks AA. Is this menopause? Women in midlife--psychosocial issues. Aust Fam Physician. 2004 Nov; 33(11):889-93.
Murkies A. If not hormones--then what? Aust Fam Physician. 2004 Nov; 33(11):895-9.
Farrell E. Dysfunctional uterine bleeding. Aust Fam Physician. 2004 Nov; 33(11):906-8.
Meyer C, Milat F, McGrath BP, Cameron J, Teede HJ. Vascular dysfunction and autonomic neuropathy in Type II diabetes. Diabetic Medicine 2004; 21(7):746-51
Teede HJ. Isoflavones from red clover were not more effective than placebo in reducing postmenopausal hot flushes. Evidence based Obstet & Gyne 2004; 6(2) 95-96.
Teede HJ, Dalais FS, McGrath BP. Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women. Am J Clin Nutr. 2004; 79(3):396-401.
Nestel P, Cehun M, Chronopoulos A, DeSilva L, McGrath BP, Teede HJ. Biochanin-enriched isoflavone from red clover lowers LDL cholesterol in men. Eur J Clin Nutr. 2004; 58(3):403-8.
McHorney,CA Rust J, Golombok S, Davis SR, Bouchard C, Brown C, Basson R, Donati Sarti C, Kuznicki J, Derogatis L. The Profile of Female Sexual Function (PFSF)Ó: A Patient-Based, International, Psychometric Instrument for the Assessment of Hypoactive Sexual Desire in Oophorectomized Women Menopause.
Jackson, B.D, Teichtahl, A.J., Morris, M.E., Wluka, A.E., Davis, S.R., Cicuttini, F.M.. The effect of the knee adduction moment on tibiofemoral cartilage volume and bone size in healthy women. Rheumatology 2004 Mar; 43(3):311-4.
Somboonporn W, Davis SR. Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women . Endocrine Reviews 2004; 25(3):374-388.
Wluka, A.E., Wolfe, R., Davis, S.R., Stuckey, S., Cicuttini, F.M. Tibial cartilage volume change in healthy postmenopausal women: a longitudinal study. Ann Rheum Dis 2004 ; 63:444-449
Rivera-Woll LM, Davis SR. Postmenopausal hormone therapy - the pros and cons. Int Med J 2004 Mar; 34(3):109-14.
Davis SR, O'Neill, Eden J, Baber R, Ekangaki A Stocks JM, Thiebaud D. Transition to raloxifene with and without low dose estrogen therapy: effects on the endometrium and patient satisfaction. Menopause 2004 Mar-Apr; 11(2):167-75
Flavia Cicuttini, Anita Wluka, Susan Davis, Boyd Strauss Stella Yeung Peter Ebeling. Association between knee cartilage volume and bone mineral density in older adults without osteoarthritis. Rheumatology
Rivera-Woll LM, Papalia, M-A, Davis SR, Burger HG. Clinical impact of androgen insufficiency in women. Update in Human Reproduction
Misso ML, Jang C, Adams J, Tran J, Murata Y, Bell R, Chin Boon W, Simpson ER, Davis SR. Adipose aromatase gene expression increases following menopause and is unaffected by postmenopausal estrogen therapy. Menopause
Somboonporn W, Davis SR. Postmenopausal Testosterone Therapy and Breast Cancer Risk. Maturitas
Davis, SR. The use of testosterone after menopause. J Br Menopause Soc
Davis SR, Guay AT, Shifren JL, Mazer NA. Endocrine Aspects of Female Sexual Dysfunction. In: 2nd International Consultation on Erectile and Sexual Dysfunction. Eds T Lue, S Khoury
Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis SR, Simpson ER, Carani C. Dysmetabolic Syndrome in a man with a novel mutation of the aromatase gene: effects of Testosterone, Alendronate and Estradiol treatment. Clin Endo Metab 2004
Teede, HJ, McGrath BP. Oestrogens and the cardiovascular system. Clinical Science 2003; 105:9-10
Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A, Nestel P. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol. 2003; 23(6):1066-71
Teede HJ. Hormone Replacement Therapy and the effects on cardiovascular and cerebrovascular disease. Best Practice Clin Endocrinol Metab. 2003; 17(1):73-90.
Dalais FS, Ebeling P, Kotsopoulos D, McGrath BP, Teede HJ. The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women Clin Endo 2003; 58(6):704-9.
Teede HJ. Hormones and thromboembolism in Hormone Replacement Therapy. Burger H, Teede HJ.( eds) Ballieres Best Practice Clin Endocrinol Metab. 2003; 17(1):73-90
Burger H, Teede HJ. Update on HT. Editorial Burger H, Teede HJ.( eds) Ballieres Best Practice Clin Endocrinol Metab. 2003; 17. (1); 1-2
Davison SL, Davis SR. Androgens in women. J Steroid Biochem Mol Biol. 2003 Jun; 85(2-5):363-6.
Cicuttini FM, Wluka AE, Wang Y, Stuckey SL, Davis SR. Effect of estrogen replacement therapy on patella cartilage in healthy women. Clinical and Experimental Rheumatology, Clin Exp Rheumatol. 2003 Jan-Feb; 21(1):79-82.
Davison S, Davis SR. Hormone replacement therapies: current controversies. Clin Endocrinol 2003; 58(3): 249-261.
Davis SR, Simpson ER. Tibolone was associated with an increase in 7 alpha-methyl-ethinylestradiol. Menopause. 2003 Jan-Feb; 10(1):105-6; author reply 106-7.
Davis SR, Burger HG. The role of androgen therapy. Best Pract Res Clin Endocrinol Metab. 2003; 17;1:165-175.
Davis SR Knight S, Davis BJ, Bell R. Climacteric symptoms among indigenous Australian women and a model for the use of culturally relevant art in health promotion. Menopause2003; 10;4:345-351.
Davis SR, Bradbury J, Bell R, Johns JA. Acute administration of conjugated equine estrogen does not improve exercise induced myocardial ischaemia in men with coronary artery disease. Intern Med J. 2003 May; 33(5-6):221-4.
Papalia M-A, Davis SR What is the rationale for androgen therapy for women. Treatments in Endocrinology 2003; 2:(2)77-84.
Davis SR. Menopause: New Therapies.2003 Med J Aust 2003; 178: 634-637.
Goldstat R, Briganti E, Tran J, Wolf R, Davis SR. Transdermal testosterone improves well being, mood and sexual function in premenopausal women. Menopause 2003; 10(5):390-398.
Davison, S, Davis SR New markers for cardiovascular disease risk in women -impact of endogenous estrogen status and exogenous estrogen treatment. J Clin Endocrinol Metab 2003; 88 (6) 2470-2478 .
Teichtahl A, Jackson B, Morris M, Wluka A, Baker R, Davis SR, Cicuttini F. The relationship between knee flexion during walking and patella carlilage and bone volume in healthy women. 2004 Rheumatology.
Davis SR Knight S, Davis BJ, Bell R Aminina Nud Mulumuluna (You gotta look after yourself) An evaluation of the use of traditional art in health promotion for Aboriginal people in the Kimberley regions of Western Australia. Australian Psycologist 2004.
Davis SR, O'Neill, Eden J, Baber R, Ekangaki A Stocks JM, Thiebaud D. Transition to raloxifene with and without low dose estrogen therapy: effects on the endometrium and patient satisfaction. Menopause 2004.
O'Neill SM, Eden J, Baber R, Ekangaki A, Stocks JM, Wolthers T, Davis SR. Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogen - a pilot study. Climacteric. 2003 Dec; 6(4):347-53.
Teede HJ. Hormone Replacement Therapy and the prevention of cardiovascular disease. Human Reproduction Update, 2002; 8(3):201-25.
Teede HJ. Controversies in HRT. Aust Fam Phys 2002; 31(5):413-8.
Cicuttini,FM, Wluka AE, Wang Y, Davis SR, Hankin J, Ebeling P. Compartment differences in knee cartilage volume in healthy adults. J Rheumatol 2002; 29 (3) 554-556.
Davis SR, Goldstat R, Newman A, Berry, K, Burger HG, Meredith I, Koch K. Differing effects of low dose estrogen and progestin replacement therapy and pravastatin in hypercholesterolemic postmenopausal women. Climacteric 2002; 5:341-350.
Britt KL, Kerr J, O'Donnell L, Jones ME, Drummond AE, Davis SR, Simpson ER, Findlay JK. Oestrogen regulates development of the somatic cell phenotype in the eutherian ovary FASEB 2002; 16(11):1389-97.
Davis SR. How to treat: management of menopause after breast cancer. Australian Doctor March 2002.
Bachmann, G Bancroft, J, Braunstein, G, Burger, H Davis SR, Dennerstein, L, Goldstein,I, Guay, A, Leiblum, S, Lobo, R, Notelovitz, M., Rosen, R, Sarrel P, Sherwin, B, Simon, J, Simpson, ER, Shifren, J, Spark, RM.D, Traish, A. Female Androgen Insufficiency: The Princeton Consensus Statement On Definition, Classification And Assessment. Fertility Sterility 2002; 77(4): 660-665 .
Davis SR. Effects of tibolone on mood and libido Menopause 2002; 9(3):162-170.
Davis SR. Postmenopausal hormone replacement therapy. N Eng J Med 2002; 346(1):63-5 (LETTER).
Burger HGB, Davis SR. The role of androgen therapy. Best Pract Res Clin Obstet Gynaecol. 2002 Jun; 16(3):383-93. (Review)
Davis SR. When to suspect androgen deficiency other than at menopause Fertility Sterility 2002; 77(4)S4:68-71.
Leventhal Alexander J, Kotz K, Davis S. Estrogen and Androgen: Mood, Sexual Function, and Quality of Life in the Menopausal Woman. In: Lobo RA, Crosignani PG, Paoletti R, Bruschi F, editors. Women's Health and Menopause: New Strategies - Improved Quality of Life. Kluwer Academic Publishers: Dordrecht, The Netherlands, 2002 (in press).
Guay, A, Davis SR. Testosterone insufficiency in women: fact or fiction? World Journal of Urology 2002; 20(2):106-10.
Bass SL, Bennell KL, Cameron ID, Davis SR, et al. Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit. Med J Aust 2002; 176: S1-S16.
Davis SR, Knight S, White, V, Claridge C., Davis BJ, Bell R. Indication of a high prevalence of polycystic ovarian syndrome in Australian Indigenous women. Gynecol Endocronol 2002; 16 443-446.
Burger HG, Davis SR. The Role of Androgen Therapy in Bailliere's Best Practice in Research Clinical Obstetrics & Gynaecologist. 2002; 16(3) 383-93.
Davis SR, Burger HG. Risks of postmenopausal hormone replacement JAMA. 2002 Dec 11; 288(22):2820. (Letter)
Teede HJ, Liang Y, Kotsopoulos D, Craven R, McGrath BP. A placebo controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Clin Endo 2001; 55:673-82.
Teede HJ, Burger H. Editorial: AHA guidelines on Hormone Replacement Therapy and Cardiovascular disease. Maturitas 2001; 40:1-3
Teede HJ, Liang Y, Kotsopoulos D, Zoungas S, Craven R, McGrath BP. A placebo controlled trial of transdermal estrogen replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Climacteric 2001; 4:1-10
Teede HJ, Van Der Zypp A, Majewski H. Gender differences in protein kinase G vasorelaxation of rat aorta. Clin Sci 2001; 100:473-9.
Peverill R, Teede H, Smolich J, Malan E, Kotsopoulos D, Tipping P, McGrath B. Effect of combined oral hormone replacement therapy on tissue factor pathway inhibitor and Factor VII. Clin Sci 2001; 101:93-9.
Teede HJ, Majewski H, McGrath BP, Turner A. Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal women. Clin Sci 2001; 100:207-213.
Worboys S, Kotsopoulos D, Teede HJ, McGrath BP, Davis S. Subcutaneous testosterone implant therapy improves endothelium-dependent and independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endo Metab 2001; 86:158-61.
Liang Y, Shiel LM, Teede HJ, Branley P, Kotsopoulos D, McNeil J, Cameron JD, McGrath BP. Effects of blood pressure, smoking and their interaction on the carotid artery: Remodelling according to Laplace law. Hypertension 2001; 37:6-11.
Wluka AE, Davis SR, White V, Bailey M, Stuckey SL, Cicuttini FM. Users of Oestrogen Replacement Therapy have more knee cartilage than Non-users. Annals Rheumatol Dis 2001; 60(4):332-6..
Jang,C, Bell R, White V, Dwyer K, Kerr PG, Davis SR. Women's health issues in haemodialysis patients: are they being addressed. MJA 2001;175:298-301.
Teede HJ, Dalais FS, Kotsopoulos D, Liang Y, McGrath BP. Soy protein dietary supplementation containing phytoestrogens improves lipid profiles and blood pressure: a double blind, randomised, placebo controlled study in men and postmenopausal women. J Clin Endo Metab 2001; 86:3053-60.
Davis SR, Briganti E, Chen R, Dalais F, Bailey M, Burger HG. The role of specific Chinese medicine in the management of postmenopausal vasomotor symptoms in Caucasian women - a randomised controlled study. MJA 2001; 174(2):68-71. [ WITH EDITORIAL]
Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis SR. Parental testosterone improves Endothelium-Dependent and Independent Vasodilation in Postmenopausal women already receiving estrogen. J Clin Endocrinol Metab 2001; 86(1) 158-161.
Simpson ER, Davis SR. Mini Review-Aromatase and the regulation of estrogen biosynthesis-some new perspectives Endocrinology 2001; 142(11): 4589-94.
Davis SR. Is phytoestrogen therapy a viable option for the management of menopausal symptoms? BMJ 2001; 323:354-5. (Invited editorial)
Tran J, Davis SR. Hirsutism, management and therapeutic options. New Ethicals Journal. 2001; October: 65-71.
Davis SR. Testosterone Deficiency in women. J Reproductive Medicine 2001; 46 (3);291-296.
Davis SR. Testosterone treatment: Psychological and physical effects in postmenopausal women. Menopausal medicine Vol 9(2) Summer 2001.
Tran J, Davis SR. Exploring the management and therapeutic options of hirsutism. Current therapeutics 2001 April; 42(4)57-61.
Davis SR. Are phytoestrogens safe for breast cancer? Medicine Today Feb 2001; 109.
Davis SR. An external perspective on the report of the International Consensus Development Conference on Female Sexual Dysfunction: More work to be done. J Sex Marital Therapy 2001; 27(2):131-133.
Davis SR, Tran J. What are "normal" testosterone levels in women? J Clin Endocrinol Metab 2001; 86(4):1842-1843. (letter)
Davis SR, Tran J. Testosterone influences libido and wellbeing. Trends in Endocrinology and Metabolism 2001; 12(1):33-37.
Teede HJ, McGrath BP, Smolich JJ, Malan E, Kotsopoulos D, Liang Y,Peverill RE. Postmenopausal hormone replacement therapy increases both coagulation activity and fibrinolysis. Arteriosclerosis Throm Vasc Biol 2000; 20(5):1404-9.
Kotsopoulos D, Dalais FS, Liang Y, McGrath BP, Teede HJ. The effects of phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000; 3:161-7.
Teede HJ, Kritharidis L. What role can diet play in the increased risk of cardiovascular disease in women aged 40 years and over? Editors H Burger, S Davis. Med J Australia 2000; 173:S93-S112.
Teede HJ, McGrath BP. Mechanism of protection against vascular smoking-induced changes by hormone replacement therapy. Letter: J Am Coll Cardiol 2000; 1; 35(3):815-6.
Lombard CB. What is the role of food in preventing depression and improving mood, performance and cognitive function?, Medical Journal of Australia 2000 Nov 6; 173 Suppl:S104-5
Murkies AL, Teede HJ, Davis SR. What is the role of phytoestrogens in treating menopausal symptoms? Med J Aust 2000; 173: Supp S97-98.
Davis SR. Identifying and promoting the specific nutrition and physical activity needs of women aged 40 and over. Summary. Med J Aust 2000; 173: Supp 109.
Davis SR. Why do women aged 40 and over need a different diet? What are their specific requirements are these met? Med J Aust 2000; 173: Supp S95-96.
Murkies A, Dalais F, Briganti E, Burger HG, Healy DL, Wahlqvist M, Davis SR. Phytoestrogen and breast cancer in postmenopausal women: a case control study. Menopause 2000; 7(5): 289-296.
Davis SR, Walker KZ, Strauss, BJG. Effects of estradiol with and without testosterone on body composition and relationships with lipids in post-menopausal women. Menopause 2000; 7(6):395-401.
Simpson ER, Rubin G, Clyne C, Roberston K, O'Donnell L, Jones M, Davis SR. The Role of Local Estrogen Biosynthesis in Males and Females. Trends in Endocrinology Metabolism 2000; 11(5)184-188.
Simpson ER, Davis SR. Another role highlighted for estrogens in the male sexual behaviour. Proc Natl Acad Sci USA 2000; 97(26):14038-40.
Davis SR. Hormones and Sexual Desire The Journal of Sex Education and Therapy. 2000; 25(1):25-32.
Davis SR. How to treat: Using androgens in women. The Australian Doctor Oct 2000.
Content updated April 4, 2011